| 0.6 |
3.9 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.4 |
1.8 |
GO:1905072 |
apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
| 0.4 |
1.4 |
GO:1904049 |
negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 0.3 |
1.5 |
GO:1905167 |
positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 0.2 |
3.7 |
GO:0002191 |
cap-dependent translational initiation(GO:0002191) |
| 0.2 |
2.5 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.2 |
2.0 |
GO:1902748 |
mammillary body development(GO:0021767) mammillary axonal complex development(GO:0061373) positive regulation of lens fiber cell differentiation(GO:1902748) |
| 0.2 |
1.0 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.2 |
0.5 |
GO:0032223 |
negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.1 |
0.6 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.1 |
0.6 |
GO:0045014 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.1 |
1.1 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.1 |
0.3 |
GO:0072361 |
regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
| 0.1 |
0.5 |
GO:1904933 |
regulation of cell proliferation in midbrain(GO:1904933) |
| 0.1 |
0.4 |
GO:1902161 |
positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
| 0.1 |
0.6 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 0.1 |
0.3 |
GO:1901842 |
negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.1 |
0.5 |
GO:0001880 |
Mullerian duct regression(GO:0001880) |
| 0.1 |
0.3 |
GO:1903570 |
regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
| 0.1 |
0.3 |
GO:1902361 |
mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 0.1 |
0.3 |
GO:0016267 |
O-glycan processing, core 1(GO:0016267) |
| 0.1 |
1.3 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 |
0.6 |
GO:0048664 |
neuron fate determination(GO:0048664) |
| 0.1 |
0.6 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 0.1 |
0.2 |
GO:0016539 |
intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
| 0.1 |
0.2 |
GO:0061760 |
antifungal innate immune response(GO:0061760) |
| 0.1 |
0.2 |
GO:0003408 |
optic cup formation involved in camera-type eye development(GO:0003408) |
| 0.1 |
1.9 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.1 |
0.2 |
GO:0052151 |
positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
| 0.1 |
0.2 |
GO:0098972 |
dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
| 0.1 |
0.2 |
GO:0036333 |
hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 0.1 |
0.3 |
GO:0002296 |
T-helper 1 cell lineage commitment(GO:0002296) |
| 0.0 |
0.0 |
GO:0060979 |
vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
| 0.0 |
0.1 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 0.0 |
0.7 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.0 |
0.7 |
GO:0002158 |
osteoclast proliferation(GO:0002158) |
| 0.0 |
0.2 |
GO:0019285 |
glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.0 |
0.4 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.0 |
0.6 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.0 |
0.2 |
GO:0043376 |
regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.0 |
0.4 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.0 |
0.5 |
GO:0042492 |
gamma-delta T cell differentiation(GO:0042492) |
| 0.0 |
1.4 |
GO:0032354 |
response to follicle-stimulating hormone(GO:0032354) |
| 0.0 |
0.3 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 0.0 |
0.4 |
GO:0035583 |
sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.0 |
0.1 |
GO:0051466 |
positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
| 0.0 |
0.2 |
GO:0008050 |
female courtship behavior(GO:0008050) |
| 0.0 |
0.6 |
GO:0043402 |
glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.0 |
0.1 |
GO:1901727 |
positive regulation of histone deacetylase activity(GO:1901727) |
| 0.0 |
0.2 |
GO:0003402 |
planar cell polarity pathway involved in axis elongation(GO:0003402) |
| 0.0 |
0.1 |
GO:0061386 |
closure of optic fissure(GO:0061386) |
| 0.0 |
0.2 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.0 |
0.1 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.0 |
0.1 |
GO:2001027 |
negative regulation of endothelial cell chemotaxis(GO:2001027) |
| 0.0 |
0.2 |
GO:1903281 |
protein transport into plasma membrane raft(GO:0044861) positive regulation of calcium:sodium antiporter activity(GO:1903281) positive regulation of potassium ion import(GO:1903288) |
| 0.0 |
0.1 |
GO:0046338 |
phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.0 |
0.7 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.0 |
0.1 |
GO:0035408 |
histone H3-T6 phosphorylation(GO:0035408) |
| 0.0 |
1.6 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.0 |
0.1 |
GO:0042660 |
positive regulation of cell fate specification(GO:0042660) |
| 0.0 |
0.2 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.0 |
0.2 |
GO:0061687 |
detoxification of inorganic compound(GO:0061687) |
| 0.0 |
0.1 |
GO:0010845 |
positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 0.0 |
0.2 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.0 |
0.3 |
GO:0002084 |
protein depalmitoylation(GO:0002084) |
| 0.0 |
0.8 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.0 |
0.2 |
GO:1902075 |
cellular response to salt(GO:1902075) |
| 0.0 |
0.2 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.0 |
0.1 |
GO:0060214 |
endocardium formation(GO:0060214) |
| 0.0 |
0.1 |
GO:1990108 |
protein linear deubiquitination(GO:1990108) |
| 0.0 |
0.1 |
GO:0000432 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.0 |
1.2 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.0 |
0.2 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.0 |
0.1 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.0 |
0.8 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.0 |
0.1 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.0 |
0.4 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.0 |
0.9 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.0 |
0.1 |
GO:2000669 |
negative regulation of dendritic cell apoptotic process(GO:2000669) |
| 0.0 |
0.2 |
GO:1904327 |
protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 0.0 |
0.1 |
GO:0006127 |
glycerophosphate shuttle(GO:0006127) |
| 0.0 |
0.1 |
GO:0034445 |
regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 0.0 |
0.1 |
GO:2000824 |
negative regulation of androgen receptor activity(GO:2000824) |
| 0.0 |
0.2 |
GO:0033183 |
negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
| 0.0 |
0.1 |
GO:0001172 |
transcription, RNA-templated(GO:0001172) |
| 0.0 |
0.2 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.0 |
0.4 |
GO:0070262 |
mitotic nuclear envelope reassembly(GO:0007084) peptidyl-serine dephosphorylation(GO:0070262) |
| 0.0 |
0.2 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.0 |
0.8 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.0 |
0.1 |
GO:2001076 |
thorax and anterior abdomen determination(GO:0007356) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
| 0.0 |
0.1 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.0 |
0.2 |
GO:0001714 |
endodermal cell fate specification(GO:0001714) |
| 0.0 |
0.4 |
GO:0000052 |
citrulline metabolic process(GO:0000052) |
| 0.0 |
0.3 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.0 |
1.1 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.0 |
0.1 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.0 |
0.1 |
GO:0060318 |
regulation of definitive erythrocyte differentiation(GO:0010724) definitive erythrocyte differentiation(GO:0060318) |
| 0.0 |
0.1 |
GO:0043335 |
protein unfolding(GO:0043335) |
| 0.0 |
0.1 |
GO:0031291 |
Ran protein signal transduction(GO:0031291) |
| 0.0 |
0.1 |
GO:0070885 |
negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.0 |
0.1 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.0 |
0.1 |
GO:2000172 |
regulation of branching morphogenesis of a nerve(GO:2000172) |
| 0.0 |
0.2 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.0 |
0.3 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.0 |
0.1 |
GO:0042659 |
regulation of cell fate specification(GO:0042659) |
| 0.0 |
0.1 |
GO:1905244 |
regulation of modification of synaptic structure(GO:1905244) |
| 0.0 |
0.1 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 0.0 |
0.1 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.0 |
0.1 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.0 |
0.1 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.0 |
0.2 |
GO:0060087 |
relaxation of vascular smooth muscle(GO:0060087) |
| 0.0 |
0.7 |
GO:0051491 |
positive regulation of filopodium assembly(GO:0051491) |
| 0.0 |
0.7 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.0 |
0.2 |
GO:2000465 |
regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.0 |
0.2 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.0 |
0.0 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.0 |
0.1 |
GO:2000074 |
regulation of type B pancreatic cell development(GO:2000074) |
| 0.0 |
0.2 |
GO:0070070 |
proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.0 |
0.1 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.0 |
0.2 |
GO:0010944 |
negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.0 |
0.1 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.0 |
1.0 |
GO:0015914 |
phospholipid transport(GO:0015914) |
| 0.0 |
0.2 |
GO:2000096 |
positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.0 |
0.1 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.0 |
0.1 |
GO:0072752 |
cellular response to rapamycin(GO:0072752) |
| 0.0 |
0.1 |
GO:0034770 |
histone H4-K20 methylation(GO:0034770) |
| 0.0 |
0.1 |
GO:0035279 |
mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.0 |
0.1 |
GO:1904936 |
cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.0 |
0.1 |
GO:2001028 |
positive regulation of endothelial cell chemotaxis(GO:2001028) |
| 0.0 |
0.1 |
GO:0031577 |
spindle checkpoint(GO:0031577) |
| 0.0 |
0.4 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.0 |
0.1 |
GO:0048105 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 0.0 |
0.0 |
GO:0061181 |
regulation of chondrocyte development(GO:0061181) |
